Characterization of a pathogenic variant in GBA for Parkinson’s disease with mild cognitive impairment patients

Parkinson’s disease (PD) is the second most common neurodegenerative disease, and mild cognitive impairment (MCI) is a well-established risk factor for the development of dementia in PD. A growing body of evidence suggests that low expression of glucocerebrosidase (GBA) promotes the transmission of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhiqiang, Huang, Yilin, Zhang, Piao, Han, Chongyin, Lu, Yueer, Mo, Zongchao, Zhang, Zhanyu, Li, Xin, Zhao, Sisi, Cai, Fuqiang, Huang, Lizhen, Chen, Chunbo, Shi, Zhihong, Zhang, Yuhu, Ling, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346430/
https://www.ncbi.nlm.nih.gov/pubmed/32641146
http://dx.doi.org/10.1186/s13041-020-00637-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346430/
https://www.ncbi.nlm.nih.gov/pubmed/32641146
http://dx.doi.org/10.1186/s13041-020-00637-x

Ejemplares similares